𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Tissue plasminogen activator and obstructed central venous catheters

✍ Scribed by Kleta, Robert; Schleef, Jürgen; Jürgens, Heribert


Publisher
John Wiley and Sons
Year
1998
Tongue
English
Weight
19 KB
Volume
30
Category
Article
ISSN
0098-1532

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


TISSUE PLASMINOGEN ACTIVATOR PRODUCTION
✍ SOO, K. S.; NORTHEAST, A. D. R.; HAPPERFIELD, L. C.; BURNAND, K. G.; BOBROW, L. 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 794 KB

## Laminated occlusive thrombus was induced in the rat inferior vena cava (IVC) by a distal stenosis and injection of thrombin. Immunocytochemistry was performed on serial cryostat sections of the thrombus for tissue plasminogen activator (tPA) and a variety of phenotype markers for mononuclear ce

Effect of oral defibrotide on tissue-pla
✍ F. Violi; D. Ferro; M. Saliola; C. Quintarelli; S. Basili; F. Balsano 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 491 KB

Defibrotide, a polydeoxyribonucleotide of mammalian origin, has been shown to reduce the blood level of the plasminogen activator inhibitor, and so to increase the activity of tissue plasminogen activator without any adverse effect. A randomized, double-blind, placebo-controlled study has been done

Tissue plasminogen activator and glial f
✍ Iordanis Gravanis; Stella E. Tsirka 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB

## Abstract Tissue plasminogen activator (tPA) is the only FDA‐approved treatment of thrombotic stroke and is a major parenchymal serine protease in the brain. However, it has been implicated in a plethora of brain pathologies, raising concern about its use as a safe therapeutic. tPA is thought to